DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lonza Group
Lonza Group
Fund Holdings
Alcon-20-F-2020.Pdf
Corporate Governance Report
Annual Report 2015
Supreme Court of the United States
Annual Report 2016 Corporate Governance Report Segments Financial Report Company Remuneration Report
Schedule of Investments International Equity Portfolio^ (Unaudited) September 30, 2020
LONZA FINANCE INTERNATIONAL NV (Incorporated in Belgium As a Société Anonyme/Naamloze Vennootschap)
For a Resilient Future
Full-Year Results 2020 Pierre-Alain Ruffieux, CEO Rodolfo Savitzky, CFO
Fund Risk Management
News Release
ANNUAL REPORT FINANCIAL REPORT REMUNERATION REPORT CORPORATE GOVERNANCE REPORT 2014 Singapore
11.25% P.A. CHF Autocall Barrier Reverse
Roche Annual Report 2006
Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries
Lonza Prices CHF 150 Million Straight-Bond with a 0.350% Coupon
Schedule of Investments (Unaudited) Blackrock Health Sciences Trust II (BMEZ) (Percentages Shown Are Based on Net Assets) September 30, 2020
Top View
Investor Relations
Sustainability Report 2020
MSCI Switzerland ESG Leaders Index (CHF)
Lonza Swiss Finanz AG 1.00 Per Cent Bonds 2020–2023 of CHF 300,000,000 Lonza Group
Supreme Court of the United States
Lonza Announces Results of the 2017 Annual General Meeting – All Motions Proposed by Board of Directors Accepted
Clarity on Mergers & Acquisitions
Lonza Annual Report 2008
Vontobel Documentation Derivatives
Investor Relations
Credit Suisse AG (Incorporated with Limited Liability in Switzerland)
MEDIA RELEASE Moderna and Lonza Announce Worldwide
Half-Year Report 2020
Eurex Circular 090/00
Lonza Annual Report 2007 Worldreginfo - 6B862aab-D1a3-4Cde-9974-0B2fd4a6bb84 Worldreginfo - 6B862aab-D1a3-4Cde-9974-0B2fd4a6bb84 Annual Report Contents 3
Lonza Annual Report 2020.Pdf
Financial Statements
E U R E X Circular 87/99
Corporate Governance
Lonza Reports Record-Breaking Full-Year Results 2017 with Double-Digit Lonza Standalone Sales Growth and More Than 26% CORE EBIT
Andreas Bohrer
Offre De Sous-Jacents D'ubs Sur Swiss DOTS
Full-Year Report 2019
Annual Report 2017
Remuneration
Full-Year Results Presentation
Results of Zrating Study 2020 on Corporate Governance
Portfolio Holdings Listing Fidelity Advisor Asset Manager 30% As of July 30, 2021
003/02-15.01.02-Contract Size of the Eurex Stock Option on the Swiss
FORM 20-F Alcon Inc
Press Release Preagm2017 EN
Roche Annual Report 2008
Louisiana Connection Switzerland
The Annual Report on the Most Valuable Swiss Brands July 2018 Foreword
E U R E X Circular 104/99
Investor Update Lonza’S Blueprint for the Future
Companies Analysed in the CDP Europe Report
Citi Pure Risk Europe Long-Short Net TR Series II Index (CIISLRE2)
Fund Risk Management
Roche Finance Report 09
Healthcare Continuum and the Capsugel Acquisition Backup Slides Lonza at a Glance
Pharma & Biotech
Corporate Governance Report 30 June 2017 Situation at 30 June 2017
Victory Fund Holdings Victory Trivalent